Exhaled eicosanoid profiles in children with atopic asthma and healthy controls

Pediatric Pulmonology

Volumn 48, Issue 4, 2013, Pages 324-335

  Glowacka, Edyta ^a   Jedynak Wasowicz, Urszula ^b   Sanak, Marek ^b   Lis, Grzegorz ^b  

^a University Children Hospital   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

children asthma; diagnosis; eicosanoids; exhaled breath condensate; high performance liquid chromatography tandem mass spectrometry

Indexed keywords

ICOSANOID; NITRIC OXIDE;

ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT PARAMETERS; SCHOOL CHILD; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; EICOSANOIC ACIDS; EXERCISE TEST; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NITRIC OXIDE; ROC CURVE; SKIN TESTS; TANDEM MASS SPECTROMETRY;

EID: 84884213248     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22615     Document Type: Article

References (44)

1. Effros RM,. Exhaled breath condensate: delusion or dilution ? Chest 2010; 138: 471-472.
2. Hunt J,. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 2002; 110: 28-34. (Pubitemid 36132721)
3. Kharitonov SA, Barnes PJ,. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1693-1722. (Pubitemid 32578777)
4. Kazani S, Israel E,. Exhaled breath condensates in asthma: diagnostic and therapeutic implications. J Breath Res 2010; 4: 047001.
5. Bayley DL, Abusriwil H, Ahmad A, Stockley RA,. Validation of assays for inflammatory mediators in exhaled breath condensate. Eur Respir J 2008; 31: 943-948.
6. Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, Bodini A, Piacentini G, Zacchello F, Zanconato S,. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003; 58: 505-509. (Pubitemid 36714012)
7. Carraro S, Corradi M, Zanconato S, Alinovi R, Pasquale MF, Zacchello F, Baraldi E,. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005; 115: 764-770. (Pubitemid 40460851)
8. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, Barnes PJ,. Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2002; 166: 1345-1349. (Pubitemid 35292700)
9. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S,. Prostaglandin E2 in the expired breath condensate of patients with asthma. Eur Respir J 2003; 22: 743-747. (Pubitemid 37369561)
10. Montuschi P, Barnes PJ,. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002; 109: 615-620. (Pubitemid 34327186)
11. Sanak M, Gielicz A, Nagraba K, Kaszuba M, Kumik J, Szczeklik A,. Targeted eicosanoids lipidomics of exhaled breath condensate in healthy subjects. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878: 1796-1800.
12. Sanak M, Gielicz A, Bochenek G, Kaszuba M, Nizankowska-Mogilnicka E, Szczeklik A,. Targeted eicosanoid lipidomics of exhaled breath condensate provide a distinct pattern in the aspirin-intolerant asthma phenotype. J Allergy Clin Immunol 2011; 127: 1141-1147.
13. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA). http://www.ginasthma.com. 2008. Ref Type: Online Source.
14. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB,. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004; 113: 59-65. (Pubitemid 38096162)
15. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJ, Corradi M, Dekhuijzen R, Dweik RA, Dwyer T, Effros R, Erzurum S, Gaston B, Gessner C, Greening A, Ho LP, Hohlfeld J, Jobsis Q, Laskowski D, Loukides S, Marlin D, Montuschi P, Olin AC, Redington AE, Reinhold P, van Rensen EL, Rubinstein I, Silkoff P, Toren K, Vass G, Vogelberg C, Wirtz H,. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548. (Pubitemid 41264218)
16. Joint Statement of the American Thoracic Society (ATS) and the European Respiratory Society (ERS). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930.
17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J,. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338. (Pubitemid 41079078)
18. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ,. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161: 309-329.
19. Weiler JM, Bonini S, Coifman R, Craig T, Delgado L, Capao-Filipe M, Passali D, Randolph C, Storms W,. American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol 2007; 119: 1349-1358. (Pubitemid 46855860)
20. Osborne JW,. Improving your data transformations: applying the Box-Cox transformation. Pract Assess Res Eval 2010; 15: 1-9.
21. Akaike H,. A new look at the statistical model identification. IEEE Trans Automatic Control 1974; 19: 716-723.
22. Montuschi P,. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis 2007; 1: 5-23.
23. Brasier AR, Victor S, Boetticher G, Ju H, Lee C, Bleecker ER, Castro M, Busse WW, Calhoun WJ,. Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines. J Allergy Clin Immunol 2008; 121: 30-37.
24. Kharitonov SA, Yates DH, Barnes PJ,. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153: 454-457. (Pubitemid 26026889)
25. Tsujino I, Nishimura M, Kamachi A, Makita H, Munakata M, Miyamoto K, Kawakami Y,. Exhaled nitric oxide-is it really a good marker of airway inflammation in bronchial asthma ? Respiration 2000; 67: 645-651. (Pubitemid 32008891)
26. Mondino C, Ciabattoni G, Koch P, Pistelli R, Trove A, Barnes PJ, Montuschi P,. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 2004; 114: 761-767. (Pubitemid 39330244)
27. Kielbasa B, Moeller A, Sanak M, Hamacher J, Hutterli M, Cmiel A, Szczeklik A, Wildhaber JH,. Eicosanoids in exhaled breath condensates in the assessment of childhood asthma. Pediatr Allergy Immunol 2008; 19: 660-669.
28. Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G,. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol 2006; 118: 347-353. (Pubitemid 44160715)
29. Antczak A, Montuschi P, Kharitonov S, Gorski P, Barnes PJ,. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002; 166: 301-306. (Pubitemid 34864417)
30. Bochenek G, Nizankowska E, Gielicz A, Swierczynska M, Szczeklik A,. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 2004; 59: 459-464. (Pubitemid 38797516)
31. Brightling CE, Ward R, Woltmann G, Bradding P, Sheller JR, Dworski R, Pavord ID,. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000; 162: 878-882.
32. Hardy CC, Robinson C, Tattersfield AE, Holgate ST,. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 1984; 311: 209-213. (Pubitemid 14087661)
33. Murray JJ, Tonnel AB, Brash AR, Roberts LJ, Gosset P, Workman R, Capron A, Oates JA,. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986; 315: 800-804. (Pubitemid 16014343)
34. O'Sullivan S, Roquet A, Dahlen B, Dahlen S, Kumlin M,. Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy 1998; 28: 1332-1339. (Pubitemid 28559006)
35. Zanconato S, Carraro S, Corradi M, Alinovi R, Pasquale MF, Piacentini G, Zacchello F, Baraldi E,. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004; 113: 257-263. (Pubitemid 38210547)
36. Shibata A, Katsunuma T, Tomikawa M, Tan A, Yuki K, Akashi K, Eto Y,. Increased leukotriene E4 in the exhaled breath condensate of children with mild asthma. Chest 2006; 130: 1718-1722. (Pubitemid 46033424)
37. Steiss JO, Rudloff S, Landmann E, Ruckes-Nilges C, Zimmer KP, Lindemann H,. Effect of inhaled corticosteroid treatment on exhaled breath condensate leukotriene E(4) in children with mild asthma. Allergy Asthma Proc 2008; 29: 371-375.
38. Lex C, Zacharasiewicz A, Payne DN, Wilson NM, Nicholson AG, Kharitonov SA, Barnes PJ, Bush A,. Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study. Respir Res 2006; 7: 63.
39. Caballero BS, Martorell AA, Cerda Mir JC, Belda RJ, Navarro IR, Navarro SA, Felix TR, Escribano MA,. Leukotriene B4 and 8-isoprostane in exhaled breath condensate of children with episodic and persistent asthma. J Investig Allergol Clin Immunol 2010; 20: 237-243.
40. Montuschi P, Martello S, Felli M, Mondino C, Barnes PJ, Chiarotti M,. Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children. Respir Res 2005; 6: 119.
41. Levy BD, Bonnans C, Silverman ES, Palmer LJ, Marigowda G, Israel E,. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 2005; 172: 824-830. (Pubitemid 41369064)
42. Samitas K, Chorianopoulos D, Vittorakis S, Zervas E, Economidou E, Papatheodorou G, Loukides S, Gaga M,. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med 2009; 103: 750-756.
43. Bondesson E, Jansson LT, Bengtsson T, Wollmer P,. Exhaled breath condensate-site and mechanisms of formation. J Breath Res 2009; 3: 016005.
44. Huttmann EM, Greulich T, Hattesohl A, Schmid S, Noeske S, Herr C, John G, Jorres RA, Muller B, Vogelmeier C, Koczulla AR,. Comparison of two devices and two breathing patterns for exhaled breath condensate sampling. PLoS ONE 2011; 6: e27467.